InspireMD- Warrants Profit Margin

InspireMD- Warrants posts a profit margin of -415.7% as of December 2025. That compares with -335.9% in the prior-year period — down 23.8% year over year. That is below the Healthcare sector average of 14.34%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, InspireMD- Warrants's profit margin was -335.9%. The latest reading is -415.7% — a 23.8% year-over-year decrease (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 14.34% is typical. InspireMD- Warrants's -415.7% is lower that level. That is roughly 2997.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

InspireMD- Warrants's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -415.7% as of December 2025; use YoY and peer views to separate noise from signal.

Context for NSPRZ's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 14.34%), and (3) consistency with growth and profitability. This page covers the first two; InspireMD- Warrants's other metric pages and overview cover the third.